Millions of people with Medicare will soon be eligible to get discounted GLP-1 drugs for weight loss. Here's how it will work ...

The BALANCE program was intended to cover weight-loss drugs for Medicaid beneficiaries, but is delayed. A new solution with ...

Starting July 2026, Medicare will pilot the 'GLP-1 Bridge,' a temporary program allowing some retirees coverage for weight loss drugs like Wegovy and Zepbound. The initiative marks a shift from ...

The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare.

The Trump administration decided to put the pilot on hold until at least 2027.

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...

Original Medicare covers opioid treatment programs (OTPs) for opioid use disorder (OUD) from Part B. The program must be government-certified and accredited by an independent, government-approved ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Medicare insolvency is not inevitable, and it’s important to question why politicians ...

Many federal government programs are contributory programs, including Social Security, unemployment benefits, and Medicare. Other types of benefit programs are noncontributory programs. These include ...